Pharmaceutical Compositions Comprising Botulinum Neurotoxin, A Non Ionic Surfactant, Sodium Chloride And Sucrose

Patent No. EP1817051 (titled "Pharmaceutical Compositions Comprising Botulinum Neurotoxin, A Non Ionic Surfactant, Sodium Chloride And Sucrose") was filed by Ipsen on Jul 6, 2005. The application was issued on Apr 10, 2024.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALLERGANNov 24, 2015HOFFMANN EITLE
DAEWOONG PHARMACEUTICALNov 24, 2015KRAUS & LEDERER PARTGMBB
MERZ PHARMANov 20, 2015GRAF KEYSERLINGK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1817051

IPSEN
Application Number
EP05757842A
Filing Date
Jul 6, 2005
Status
Patent Maintained As Amended
Mar 8, 2024
Publication Date
Apr 10, 2024